SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.09 Cr | ₹9.84 Cr | ₹-0.48 Cr | ₹-0.18 Cr |
What is the latest Cash Flow from Financing Activities ratio of SHREE GANESH REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.09 Cr |
| Mar2024 | ₹9.84 Cr |
| Mar2020 | ₹-0.48 Cr |
| Mar2019 | ₹-0.18 Cr |
How is Cash Flow from Financing Activities of SHREE GANESH REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.09 Cr | Negative | |
| Mar2024 | ₹9.84 Cr | Positive | |
| Mar2020 | ₹-0.48 Cr | Negative | |
| Mar2019 | ₹-0.18 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹758.7 Cr | -7.1% | 17.6% | -8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | 0.6% | -2.8% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,570.0 Cr | 0.4% | 0.1% | 0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,670.0 Cr | 3.4% | 4.3% | 42% | Stock Analytics | |
| CIPLA | ₹111,725.0 Cr | -1.3% | 7% | -7.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,424.0 Cr | -0.2% | 0.4% | -1.4% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -7.1% |
17.6% |
-8% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses